The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
Sangeeta Bhatia
-
Researchers improve blood tests’ ability to detect and monitor cancer
-
Inhalable sensors could enable early lung cancer detection
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
-
A simple paper test could offer early cancer diagnosis
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
-
Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
-
New test may predict Covid-19 immunity
The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.
-
Nanoparticle sensor can distinguish between viral and bacterial pneumonia
Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective.
-
A noninvasive test to detect cancer cells and pinpoint their location
Diagnostic nanoparticles could be used to monitor tumor recurrence after treatment or to perform routine cancer screenings.
-
Faster tracking of treatment responses
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
-
Exhaled biomarkers can reveal lung disease
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.
-
New sensors could offer early detection of lung tumors
Study shows that a simple urine test can reveal the presence of lung cancer in mice.